Page last updated: 2024-10-24

guanine salvage

Definition

Target type: biologicalprocess

Any process that generates guanine, 2-amino-6-hydroxypurine, from derivatives of it without de novo synthesis. [GOC:jl]

Guanine salvage is a metabolic pathway that recovers guanine, a purine base, from degraded nucleic acids and other sources to synthesize new guanine nucleotides. This process is essential for maintaining cellular guanine nucleotide pools, which are vital for DNA replication, RNA transcription, and other cellular processes.

The guanine salvage pathway begins with the uptake of guanine from the extracellular environment or from the breakdown of cellular nucleic acids. Once inside the cell, guanine is converted to guanosine monophosphate (GMP) through a two-step enzymatic reaction.

The first step involves the phosphorylation of guanine to guanosine by the enzyme guanine phosphoribosyltransferase (GPRT). GPRT utilizes phosphoribosyl pyrophosphate (PRPP) as a donor of the phosphoribosyl group, which is attached to the guanine molecule to form guanosine.

The second step is the phosphorylation of guanosine to GMP, catalyzed by the enzyme nucleoside monophosphate kinase. This reaction uses ATP as a phosphate donor, transferring a phosphate group from ATP to the 5'-hydroxyl group of guanosine to produce GMP.

GMP is then utilized for the synthesis of other guanine nucleotides, such as GDP and GTP, through a series of enzymatic reactions. These reactions involve the addition of phosphate groups to GMP by kinases. GDP is formed by the phosphorylation of GMP by guanylate kinase, while GTP is formed by the phosphorylation of GDP by nucleoside diphosphate kinase.

Guanine salvage is a crucial process for cell survival and proliferation. By recovering guanine from degraded nucleic acids, the pathway conserves cellular energy and reduces the need for de novo purine biosynthesis, which is a more energy-intensive process.

Defects in the guanine salvage pathway can lead to various genetic diseases. For example, mutations in the GPRT gene can cause Lesch-Nyhan syndrome, a severe neurodevelopmental disorder characterized by self-injurious behavior, hyperuricemia, and gout. Deficiency in other enzymes involved in the guanine salvage pathway can also lead to various metabolic disorders.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Hypoxanthine-guanine phosphoribosyltransferaseA hypoxanthine-guanine phosphoribosyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00492]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
chrysenechrysene : An ortho-fused polycyclic arene found commonly in the coal tar.

chrysene: structure in Merck Index, 9th ed, #2252
ortho-fused polycyclic areneplant metabolite
6-chrysenamine6-chrysenamine: may cause splenic atrophy and leukopenia; minor descriptor (76-84); on-line & Index Medicus search PHENANTHRENES (76-84)carbopolycyclic compound
6-nitrochrysene6-nitrochrysene: RN given refers to cpd with locant for nitro group in position 6carbopolycyclic compound
mercaptopurinemercaptopurine : A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6. An adenine analogue, it is used in the treatment of acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML), Crohn's disease, and ulcerative colitis.

Mercaptopurine: An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.

purine-6-thiol : A thiol that is the tautomer of mercaptopurine.
aryl thiol;
purines;
thiocarbonyl compound
anticoronaviral agent;
antimetabolite;
antineoplastic agent
thioguanine anhydrousThioguanine: An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.

tioguanine : A 2-aminopurine that is the 6-thiono derivative of 2-amino-1,9-dihydro-6H-purine. Incorporates into DNA and inhibits synthesis. Used in the treatment of leukaemia.
2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
guanosine monophosphateguanosine 5'-monophosphate : A purine ribonucleoside 5'-monophosphate having guanine as the nucleobase.

Guanosine Monophosphate: A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature.
guanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate
biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
guanine2-aminopurines;
oxopurine;
purine nucleobase
algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
hypoxanthinenucleobase analogue;
oxopurine;
purine nucleobase
fundamental metabolite
inosinic acidInosine Monophosphate: Inosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety.inosine phosphate;
purine ribonucleoside 5'-monophosphate
Escherichia coli metabolite;
human metabolite;
mouse metabolite
allopurinolallopurinol : A bicyclic structure comprising a pyrazole ring fused to a hydroxy-substituted pyrimidine ring.

Allopurinol: A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.
nucleobase analogue;
organic heterobicyclic compound
antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
azaguanine8-azaguanine : A triazolopyrimidine that consists of 3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidine bearing amino and oxo substituents at positions 5 and 7 respectively.

Azaguanine: One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids.
nucleobase analogue;
triazolopyrimidines
antimetabolite;
antineoplastic agent;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor